Kestrel Therapeutics Inc.

Form D Filings

Location
Boston, MA
Industry Group
Biotechnology
Entity Type
Corporation
CIK
0001853373
All SEC Filings
View on sec.gov
Date Filed Security Types Total Amount Sold Total Offering Amount Remaining First Sale Signed Form SEC Link
2/21/2025 Debt, Option to Acquire, Security to be Acquired $8,000,000 $16,000,000 $8,000,000 2/7/2025 2/21/2025 D 000185337325000001
1/11/2022 Equity $7,500,000 $40,000,000 $32,500,000 12/28/2021 1/11/2022 D 000185337322000001
3/25/2021 Debt $228,000 $2,000,000 $1,772,000 3/1/2021 3/15/2021 D 000185337321000001